GB

Gudrun Bachmann

Chief Technology Officer

Oculis

Geneva, Geneva


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Oculis
Industry
research
Employees
58.0
Seniority
C suite
Annual Revenue
1044000.0

Technologies

Outlook Adobe Marketing Cloud Google Analytics reCAPTCHA Google Maps Gravity Forms WordPress.org Google Maps (Non Paid Users) Google Tag Manager Google Font API Shutterstock Mobile Friendly Apache Remote Data Analytics AI

Keywords

pharmaceutical ophthalmology drug delivery biotech biotechnology: pharmaceutical preparations health care biotechnology research biopharmaceutical eye care diabetic macular edema dme ocs-01 high concentration eye drop non-invasive treatment anti-vegf therapies dry eye disease ded ocs-02 anti-tnf eye drop ocular inflammation uveitis acute optic neuritis aon ocs-05 neuroprotective therapy optireach technology clinical trials pipeline patient-centric transformative innovations investigational drugs visual impairment cataract surgery post ocular surgery inflammation pain management topical administration drug passage ocular complications ocular disease patient population advanced therapies therapeutic innovation scientific approaches investors medical needs regulatory approval sight saving health improvement medical research ophthalmic products therapy development global healthcare medical innovation evidence-based medicine medical health wellness & fitness hospital & health care

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans